- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Addus HomeCare Corporation(ADUS)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for ADUS
11/20/2026: ADUS (2-star) has a low Upturn Star Rating. Not recommended to BUY.
Addus HomeCare Corporation is a prominent U.S. provider of home-based personal care, hospice, and skilled nursing services tailored for elderly and chronically ill individuals. The company's core strength lies in its reliable personal care segment, which yields steady recurring revenue backed by favorable demographic aging trends. Its primary growth strategy centers on expanding geographic density through targeted tuck-in acquisitions. However, the business remains vulnerable to state Medicaid reimbursement pressures and labor wage constraints. The stock is well-suited for growth-oriented investors willing to monitor regulatory updates and state-level funding developments.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | Addus offers consistent revenue expansion fueled by favorable long-term demographic trends and strategic tuck-in acquisitions. |
| Momentum investor | Mixed fit | The stock can experience periods of strong relative performance, though momentum is conditional on favorable sector sentiment and positive earnings revisions. |
| Value investor | Strong fit while signal remains positive | The stock trades at a reasonable forward valuation multiple relative to its earnings growth potential compared to other healthcare peers. |
| Dividend investor | Weak fit | The company does not pay dividends, prioritizing capital reinvestment for business expansion instead. |
| Low-risk investor | Mixed fit | While healthcare demand is defensive, regulatory exposure to state Medicaid policies introduces policy-related volatility. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium | The stock experiences moderate price swings driven by broader healthcare sector rotations and regulatory headlines. |
| Valuation risk | Low | Reasonable earnings multiples limit downside valuation risk under normal operating conditions. |
| Competition risk (payer and labor competition) | Medium | Intense competition for direct-care workers and nurse staffing can pressure operating margins and wage expenses. |
| Business quality | Strong | The company features a resilient asset-light business model with steady cash conversion. |
| Dividend income | Low / none | Income-focused investors receive no dividend distributions from the stock. |
| Execution risk | Medium | Successful integration of recent acquisitions and effective navigation of state reimbursement changes are vital for sustained profitability. |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.28B USD | Price to earnings Ratio 20.38 | 1Y Target Price 141.46 |
Price to earnings Ratio 20.38 | 1Y Target Price 141.46 | ||
Volume (30-day avg) 237.7K shares | Beta 0.74 | 52 Weeks Range 87.95 - 131.59 | Updated Date 11/20/2026 |
52 Weeks Range 87.95 - 131.59 | Updated Date 11/20/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 6.01 |
Sector & Industry Intelligence
Sector
Healthcare
Constructive- Sentiment
- Strong Bullish
- Momentum
- BUY Breadth Improving
- BUY participation
- 55.2%
- Active BUY / eligible
- 53 / 96
- 30-Day BUY Count Change
- +19
- Market state
- Strong Bullish
More qualifying stocks are receiving or maintaining BUY advisories, indicating improving market participation.
Industry
Medical Care Facilities
- BUY participation
- 85.7%
- Active BUY / eligible
- 6 / 7
- 30-Day BUY Count Change
- +2
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.

Smooth
The stock has moved along a generally orderly path with only modest fluctuations.
Analysis of Past Performance
Type Stock | Historic Profit 6.99% | Avg. Invested days 38 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Personal Care | Non-medical assistance with daily activities for elderly and disabled individuals, largely funded through state Medicaid programs. | This is the primary revenue engine of the company, providing stable, recurring cash flows. |
| Hospice Care | Palliative and end-of-life care services compensated primarily via Medicare per-diem reimbursements. | Offers higher margins and serves as a key complementary service line within the care continuum. |
| Home Health | Skilled nursing and physical therapy services provided after acute hospitalizations. | Represents a smaller segment that adds clinical breadth to the company's service offerings. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2026-11-03 | When After Market | Estimate 1.61 | Actual 1.71 |
Profitability
Profit Margin 7.39% | Operating Margin (TTM) 10.41% |
Management Effectiveness
Return on Assets (TTM) 6.8% | Return on Equity (TTM) 9.96% |
Valuation
Trailing PE 20.38 | Forward PE 15.9 | Enterprise Value 2.22B | Price to Sales(TTM) 1.52 |
Enterprise Value 2.22B | Price to Sales(TTM) 1.52 | ||
Enterprise Value to Revenue 1.48 | Enterprise Value to EBITDA 12.8 | Shares Outstanding 18.63M | Shares Floating 17.73M |
Shares Outstanding 18.63M | Shares Floating 17.73M | ||
Percent Insiders 2.72 | Percent Institutions 108.71 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

